发明名称 |
Pyrazole derivatives as protein kinase modulators |
摘要 |
The invention provides compounds of the formula (I) having protein kinase B inhibiting activity:
wherein A is a saturated hydrocarbon linker group containing from 1 to 7 carbon atoms, the linker group having a maximum chain length of 5 atoms extending between R 1 and NR 2 R 3 and a maximum chain length of 4 atoms extending between E and NR 2 R 3 , wherein one of the carbon atoms in the linker group may optionally be replaced by an oxygen or nitrogen atom; and wherein the carbon atoms of the linker group A may optionally bear one or more substituents selected from oxo, fluorine and hydroxy, provided that the hydroxy group when present is not located at a carbon atom ± with respect to the NR 2 R 3 group and provided that the oxo group when present is located at a carbon atom ± with respect to the NR 2 R 3 group;
E is a monocyclic or bicyclic carbocyclic or heterocyclic group;
R 1 is an aryl or heteroaryl group; and
R 2 , R 3 , R 4 and R 5 are as defined in the claims. Also provided are pharmaceutical compositions containing the compounds, methods for preparing the compounds and their use as anticancer agents. |
申请公布号 |
AU2004303602(C1) |
申请公布日期 |
2009.05.28 |
申请号 |
AU20040303602 |
申请日期 |
2004.12.23 |
申请人 |
THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL;ASTEX THERAPEUTICS LIMITED;CANCER RESEARCH TECHNOLOGY LIMITED |
发明人 |
IAN COLLINS;ROBERT DOWNHAM;VALERIO BERDINI;PAUL GRAHAM WYATT;ROBIN ARTHUR ELLIS CARR;STEVEN JOHN WOODHEAD;HANNAH FIONA SORE;ROBERT GEORGE BOYLE;MARINUS LEENDERT VERDONK;DAVID WINTER WALKER;GORDON SAXTY |
分类号 |
A61K31/415;C07D231/12;C07D401/10;C07D413/10 |
主分类号 |
A61K31/415 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|